Compounds > 1-methyl-2-nitroimidazole
Page last updated: 2024-08-21

1-methyl-2-nitroimidazole and methionine sulfoximine

1-methyl-2-nitroimidazole has been researched along with methionine sulfoximine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gipp, JJ; McClelland, RA; Mulcahy, RT1
Gipp, JJ; McClelland, RA; Mulcahy, RT; Ublacker, GA1
Gipp, JJ; McClelland, RA; Mulcahy, RT; Panicucci, R; Ublacker, GA1

Other Studies

3 other study(ies) available for 1-methyl-2-nitroimidazole and methionine sulfoximine

ArticleYear
DNA damage induced in HT-29 colon cancer cells by exposure to 1-methyl-2-nitrosoimidazole, a reductive metabolite of 1-methyl-2-nitroimidazole.
    Biochemical pharmacology, 1991, Dec-11, Volume: 42 Suppl

    Topics: Buthionine Sulfoximine; Colonic Neoplasms; DNA; DNA Damage; DNA, Neoplasm; Endopeptidase K; Humans; Hydrogen-Ion Concentration; Imidazoles; Methionine Sulfoximine; Nitroimidazoles; Nitroso Compounds; Oxidation-Reduction; Serine Endopeptidases; Tumor Cells, Cultured

1991
Enhancement of melphalan (L-PAM) toxicity by reductive metabolites of 1-methyl-2-nitroimidazole, a model nitroimidazole chemosensitizing agent.
    Biochemical pharmacology, 1990, Dec-15, Volume: 40, Issue:12

    Topics: Buthionine Sulfoximine; Cell Survival; Drug Synergism; Glutathione; Humans; In Vitro Techniques; Melphalan; Methionine Sulfoximine; Nitroimidazoles; Oxidation-Reduction; Structure-Activity Relationship; Tumor Cells, Cultured

1990
Cytotoxicity and glutathione depletion by 1-methyl-2-nitrosoimidazole in human colon cancer cells.
    Biochemical pharmacology, 1989, May-15, Volume: 38, Issue:10

    Topics: Buthionine Sulfoximine; Cell Survival; Colonic Neoplasms; Glutathione; Humans; Methionine Sulfoximine; Nitroimidazoles; Tumor Cells, Cultured

1989